Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0001104659-21-151821

Options or other derivatives

  • Chief Executive Officer acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Raykov Rosty · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-12-20 Grant or award : show line 1 in the form Stock Option (right to buy) +300,000 $4.08 2031-12-20 300,000 300,000 D
Loading xslF345X03/tm2135965-1_4seq1.xml…